Irit Yaniv

Eximo Medical Ltd. develops hybrid catheter technology for medical applications. Its technology is used for superior tissue resection invascular and gastrointestinal endoluminal applications. The firm's clinical applications include lead extraction, peripheral artery disease and gastrointestinal. The company was founded by Ilan Ben Oren and Yossi Muncher in July 2012 and is headquartered in Rehovot, Israel.

ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

Nitinotes Ltd. develops advance non-surgical bariatric solutions. The company was founded by Tamir Wolf and Irit Yaniv in 2014 and is headquartered in Ramat Gan, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Nitiloop Ltd. develops vascular support micro-catheters. It offers NovaCross, a distal guidewire supporting micro-catheter with an extendable segment for additional support. The company was founded by Ran Kornowski, Dalit Doron and Dvir Keren in 2009 and is headquartered in Netanya, Israel.

Nitinotes Ltd. develops advance non-surgical bariatric solutions. The company was founded by Tamir Wolf and Irit Yaniv in 2014 and is headquartered in Ramat Gan, Israel.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

Ziv Healthcare Ltd., also known as Cardiacare, is an Israeli clinical stage digital therapeutic company that develops the world's first closed loop wearable for non-invasive treatment of cardiac and other central nervous system related clinical symptoms. The company is based in Nes Ziona, Israel. The company's device provides a non-invasive, nerve stimulation treatment with continuous monitoring and AI-based alerts capabilities. The company was founded in 2015 by Amos Ziv. The CEO is Ofer Halbreich.

Nitiloop Ltd. develops vascular support micro-catheters. It offers NovaCross, a distal guidewire supporting micro-catheter with an extendable segment for additional support. The company was founded by Ran Kornowski, Dalit Doron and Dvir Keren in 2009 and is headquartered in Netanya, Israel.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

Eximo Medical Ltd. develops hybrid catheter technology for medical applications. Its technology is used for superior tissue resection invascular and gastrointestinal endoluminal applications. The firm's clinical applications include lead extraction, peripheral artery disease and gastrointestinal. The company was founded by Ilan Ben Oren and Yossi Muncher in July 2012 and is headquartered in Rehovot, Israel.

Ziv Healthcare Ltd., also known as Cardiacare, is an Israeli clinical stage digital therapeutic company that develops the world's first closed loop wearable for non-invasive treatment of cardiac and other central nervous system related clinical symptoms. The company is based in Nes Ziona, Israel. The company's device provides a non-invasive, nerve stimulation treatment with continuous monitoring and AI-based alerts capabilities. The company was founded in 2015 by Amos Ziv. The CEO is Ofer Halbreich.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

Eximo Medical Ltd. develops hybrid catheter technology for medical applications. Its technology is used for superior tissue resection invascular and gastrointestinal endoluminal applications. The firm's clinical applications include lead extraction, peripheral artery disease and gastrointestinal. The company was founded by Ilan Ben Oren and Yossi Muncher in July 2012 and is headquartered in Rehovot, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

Almeda Ventures LP (Almeda Ventures) is a HealthTech focused public R&D partnership venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

Nitinotes Ltd. develops advance non-surgical bariatric solutions. The company was founded by Tamir Wolf and Irit Yaniv in 2014 and is headquartered in Ramat Gan, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Nitiloop Ltd. develops vascular support micro-catheters. It offers NovaCross, a distal guidewire supporting micro-catheter with an extendable segment for additional support. The company was founded by Ran Kornowski, Dalit Doron and Dvir Keren in 2009 and is headquartered in Netanya, Israel.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

Ziv Healthcare Ltd., also known as Cardiacare, is an Israeli clinical stage digital therapeutic company that develops the world's first closed loop wearable for non-invasive treatment of cardiac and other central nervous system related clinical symptoms. The company is based in Nes Ziona, Israel. The company's device provides a non-invasive, nerve stimulation treatment with continuous monitoring and AI-based alerts capabilities. The company was founded in 2015 by Amos Ziv. The CEO is Ofer Halbreich.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

EndoSpan Ltd. develops novel endovascular system for endovascular aortic aneurysm repair. The firm is opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The company was founded by Rafi Benary and Alon Shalev in 2009 and is headquartered in Herzlia, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.